Back To Top

Would you like to receive our newsletter?

You can stay informed about the latest news from ACCESS Health International! Enter your email address and first name and click Sign Up!

Collaborative Commercialization at Gilead Sciences: Resolving the Innovation vs Access Tradeoff

Print Friendly

This article looks at the development of innovative market based strategies by Gilead Sciences to improve access to HIV drugs in the Indian market through strategic manufacturing, licensing, and distribution partnerships and collaborations with the Indian generic drug industry.

Modern Aging: inspiring and empowering entrepreneurs of all ages and backgrounds to create businesses to serve the needs of the elderly.
We are no longer active in Collaborative Commercialization at Gilead Sciences: Resolving the Innovation vs Access Tradeoff. Projects and resources are available in the archive.